COMPASS Pathways Stock (NASDAQ:CMPS)

Forecast Ownership Financials Chart Transcripts

Previous Close

$3.02

52W Range

$2.49 - $9.63

50D Avg

$3.55

200D Avg

$5.20

Market Cap

$204.97M

Avg Vol (3M)

$1.09M

Beta

2.35

Div Yield

CMPS Company Profile

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

Employees

166

IPO Date

Sep 18, 2020

Website

CMPS Performance

CMPS Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-178.21M	$-136.92M	$-110.40M
Net Income	$-155.12M	$-118.46M	$-91.50M
EBITDA	$-178.21M	$-123.80M	$-110.40M
Basic EPS	$-2.30	$-2.32	$-2.16
Diluted EPS	$-2.30	$-2.32	$-2.16

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Feb 27, 25 | 8:00 AM

Q3 24Oct 31, 24 | 8:00 AM

Q2 24Aug 04, 24 | 8:00 AM

Peer Comparison

Ticker	Company
AGL	agilon health, inc.
USPH	U.S. Physical Therapy, Inc.
ACHC	Acadia Healthcare Company, Inc.
AMED	Amedisys, Inc.
DVA	DaVita Inc.
ADUS	Addus HomeCare Corporation
SGRY	Surgery Partners, Inc.
CCRN	Cross Country Healthcare, Inc.
INNV	InnovAge Holding Corp.
EHAB	Enhabit, Inc.
ENSG	The Ensign Group, Inc.
PNTG	The Pennant Group, Inc.